Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.70 Insider Own2.30% Shs Outstand91.45M Perf Week7.84%
Market Cap1.37B Forward P/E74.26 EPS next Y0.20 Insider Trans-6.07% Shs Float89.37M Perf Month-3.10%
Income-58.20M PEG- EPS next Q-0.25 Inst Own83.20% Short Float22.08% Perf Quarter6.84%
Sales10.00M P/S137.18 EPS this Y-65.70% Inst Trans9.51% Short Ratio12.01 Perf Half Y-0.66%
Book/sh1.63 P/B9.20 EPS next Y125.30% ROA-61.20% Target Price24.00 Perf Year63.40%
Cash/sh1.69 P/C8.85 EPS next 5Y30.00% ROE-72.60% 52W Range8.29 - 17.46 Perf YTD15.83%
Dividend- P/FCF- EPS past 5Y13.20% ROI-103.70% 52W High-11.97% Beta3.25
Dividend %- Quick Ratio9.50 Sales past 5Y42.30% Gross Margin- 52W Low85.40% ATR0.56
Employees59 Current Ratio9.50 Sales Q/Q42.90% Oper. Margin- RSI (14)59.70 Volatility3.39% 3.95%
OptionableYes Debt/Eq0.00 EPS Q/Q-400.00% Profit Margin- Rel Volume0.74 Prev Close15.00
ShortableYes LT Debt/Eq0.00 EarningsJul 29 Payout- Avg Volume1.64M Price15.37
Recom1.60 SMA203.05% SMA507.08% SMA20010.16% Volume576,965 Change2.47%
23-May-14Reiterated H.C. Wainwright Buy $19
12-May-14Reiterated MLV & Co Buy $27 → $21
04-Apr-14Reiterated Ladenburg Thalmann Buy $24 → $30
02-Apr-14Reiterated Mizuho Buy $25 → $34
01-Apr-14Reiterated Oppenheimer Outperform $20 → $22
21-Mar-14Initiated Mizuho Buy $25
14-Mar-14Reiterated Stifel Buy $17 → $19
27-Jan-14Reiterated Maxim Group Buy $16 → $25
17-Oct-13Reiterated Ladenburg Thalmann Buy $15 → $19
01-Aug-13Reiterated Maxim Group Buy $9 → $12
29-Jan-13Reiterated Stifel Nicolaus Buy $4 → $13
29-Jan-13Reiterated MLV & Co Buy $5 → $15
29-Jan-13Reiterated Ladenburg Thalmann Buy $5 → $15
29-Jan-13Reiterated Burrill Institutional Research Mkt Outperform $6 → $11
28-Jan-13Reiterated Maxim Group Buy $4 → $9
13-Dec-12Initiated Maxim Group Buy $4
13-Nov-12Initiated Burrill Institutional Research Mkt Outperform $6
10-Oct-12Reiterated Ladenburg Thalmann Buy $3 → $5
10-May-12Upgrade Ladenburg Thalmann Neutral → Buy $3
03-Apr-12Downgrade Ladenburg Thalmann Buy → Neutral
24-Jul-14 05:00PM  Keryx drug improves phosphorus, iron in kidney patients -trial Reuters
05:00PM  Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology GlobeNewswire
22-Jul-14 08:46AM  Should You Join This Major Hedge Fund in Buying Keryx Stock? at Motley Fool
24-Jun-14 05:01PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05:01PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
08:00AM  Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains at Seeking Alpha
08:00AM  Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains
18-Jun-14 08:30AM  Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate GlobeNewswire
08:30AM  Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate
17-Jun-14 04:30PM  Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference GlobeNewswire
04:30PM  Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference
06-Jun-14 06:02PM  4 Reasons Why Wall Street Hates Keryx Biopharmaceuticals Inc. at Motley Fool
06:02PM  4 Reasons Why Wall Street Hates Keryx Biopharmaceuticals Inc.
09:00AM  The Baupost Group buys a new position in Keryx Biopharmaceuticals Market Realist
09:00AM  The Baupost Group buys a new position in Keryx Biopharmaceuticals
05-Jun-14 12:33PM  Must-know highlights of the Baupost Groups 1Q 2014 positions Market Realist
12:33PM  Must-know highlights of the Baupost Groups 1Q 2014 positions
08:30AM  Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference GlobeNewswire
08:30AM  Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference
29-May-14 07:34PM  Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation at Seeking Alpha
07:34PM  Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation
23-May-14 11:00AM  Options with decreasing implied volatility at theflyonthewall.com
11:00AM  Options with decreasing implied volatility
08:48AM  Today's Top Health Care Stocks to Watch: PTC Therapeutics, Inovio Pharmaceuticals and Keryx Biopharmaceuticals at Motley Fool
08:48AM  Today's Top Health Care Stocks to Watch: PTC Therapeutics, Inovio Pharmaceuticals and Keryx Biopharmaceuticals
07:30AM  Keryx PDUFA extension creates buying opportunity, says Oppenheimer at theflyonthewall.com
07:30AM  Keryx PDUFA extension creates buying opportunity, says Oppenheimer
22-May-14 05:21PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:33PM  Keryx announces FDA extends PDUFA date for Zerenex at theflyonthewall.com
04:30PM  Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM) GlobeNewswire
19-May-14 05:35PM  Biotech Tweet of the Week: Investing in Moldy Pizza at Motley Fool
11:40AM  Seth Klarman's Baupost: Investment Changes During The First Quarter at Seeking Alpha
11:20AM  Deerfield reports 4.87% passive stake in Keryx at theflyonthewall.com
16-May-14 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials EDGAR Online Financials
12-May-14 06:43PM  Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals Gurufocus +5.20%
09:22AM  2014 FDA Drug Approval Calendar at TheStreet
08:12AM  UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk Benzinga
09-May-14 04:03PM  The Baupost Group reports 10.07% passive stake in Keryx at theflyonthewall.com
08-May-14 03:42PM  Why Keryx Biopharmaceuticals (KERX) Stock Is Down Today at TheStreet -13.72%
02:31PM  Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
01:10PM  Why Keryx Biopharmaceuticals, Inc. Shares Swooned at Motley Fool
12:16PM  Keryx weakness a buying opportunity, says Brean Capital at theflyonthewall.com
11:31AM  Keryx June volatility elevated into PDUFA at theflyonthewall.com
08:00AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:00 am ET today CCBN
07:49AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:00 am ET today CCBN
07:22AM  Keryx reports Q1 EPS (15c), consensus (8c) at theflyonthewall.com
07:18AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q1 2014 Keryx Biopharmaceuticals, Inc. Earnings Release - Time Not Supplied CCBN
07:00AM  Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results GlobeNewswire
06-May-14 08:00AM  Keryx Biopharmaceuticals Announces Opening of Boston Office GlobeNewswire
05-May-14 04:30PM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results GlobeNewswire
01-May-14 10:05AM  Cytokinetics Binary Failure Provides Solid Opportunity at Seeking Alpha
10:05AM  Cytokinetics Binary Failure Provides Solid Buying Opportunity at Seeking Alpha
25-Apr-14 11:56AM  Glenn R. Mattes, the President, CEO and Director of Arno Therapeutics, Inc. (ARNI), Interviews with The Wall Street Transcript Wall Street Transcript
23-Apr-14 04:32PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
16-Apr-14 10:45AM  Keryx Biopharmaceuticals: Is The High Valuation Justified? at Seeking Alpha
15-Apr-14 08:30AM  Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal GlobeNewswire
11-Apr-14 09:00AM  Reviewing An Aggressive Strategy In A Volatile Market at Forbes
09-Apr-14 08:30AM  Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2 GlobeNewswire
03-Apr-14 05:20PM  Good News for Keryx Zacks
02-Apr-14 09:22AM  Keryx price target raised to $34 from $25 at Mizuho at theflyonthewall.com
08:30AM  Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) GlobeNewswire
01-Apr-14 08:30AM  High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued at Seeking Alpha
31-Mar-14 03:10PM  Medicare Band-Aid Sends 1 Biotech Stock Surging at Motley Fool
29-Mar-14 08:15AM  3 Humongous Health-Care Stocks This Week at Motley Fool
27-Mar-14 11:52AM  Use Options For A Chance To Buy KERX At A 39% Discount at TheStreet
02:39AM  Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% Zacks
26-Mar-14 07:17PM  Keryx CEO Says U.S. House Bill Would Help on Drug Pricing at Bloomberg +17.39%
05:15PM  Why Keryx Biopharmaceuticals, Yongye International, and Five Below Are Today's 3 Best Stocks at Motley Fool
21-Mar-14 06:31AM  Coverage initiated on Keryx Biopharma by Mizuho Briefing.com
19-Mar-14 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials EDGAR Online Financials
17-Mar-14 08:30AM  Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo GlobeNewswire
13-Mar-14 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
01:25PM  Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
01:25PM  Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
12:20PM  Wider Q4 Loss at Keryx Zacks
12:20PM  Wider Q4 Loss at Keryx
08:30AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
12-Mar-14 05:24PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events EDGAR Online
04:30PM  Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results GlobeNewswire
11-Mar-14 04:30PM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results GlobeNewswire
10-Mar-14 08:50AM  Keryx announces submission of MAA for Zerenex to EMA at theflyonthewall.com
08:50AM  Keryx announces submission of MAA for Zerenex to EMA
08:30AM  Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency GlobeNewswire
26-Feb-14 03:27PM  Six stocks to watch at MarketWatch
08:30AM  Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire
25-Feb-14 02:15PM  [video] TG Therapeutics CEO: Stock Volatile But Cancer Drugs on Track at TheStreet
08:48AM  Ferric Citrate [Zerenex] For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound at Seeking Alpha
18-Feb-14 08:30AM  Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing GlobeNewswire
10-Feb-14 05:04PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
08:34AM  Keryx appoints Appoints Greg Madison as COO theflyonthewall.com
08:30AM  Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer GlobeNewswire
06-Feb-14 08:30AM  Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference GlobeNewswire
30-Jan-14 12:30PM  [video] Joe Theismann's investing playbook at CNBC
12:30PM  [video] Joe Theismann's investing playbook
05:57AM  Investors are betting against Keryx Biopharmaceuticals (KERX), Should You? Zacks
05:57AM  Investors are betting against Keryx Biopharmaceuticals (KERX), Should You?
05:53AM  Keryx Biopharmaceuticals (KERX) Shares March Higher, Can It Continue? Zacks
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company has completed Phase III clinical program for Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with chronic kidney disease on dialysis. Zerenex has also completed a Phase II study for the management of elevated serum phosphorus levels and iron deficiency anemia in patients with stages three to five non-dialysis dependent chronic kidney disease. The company has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. It also has strategic alliances with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChief Executive OfficerJul 07Sale15.751,78828,161876,815Jul 09 08:00 PM
Oliviero James F IIIChief Financial OfficerJul 07Sale15.752,05432,351300,276Jul 09 08:00 PM
Oliviero James F IIIChief Financial OfficerApr 03Sale16.462,08734,352302,330Apr 07 07:24 PM
BENTSUR RONChief Executive OfficerApr 03Sale16.461,81629,891878,603Apr 07 07:18 PM
Oliviero James F IIIChief Financial OfficerMar 21Sale15.1113,444203,139304,417Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 20Sale15.04125,0001,880,000317,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Option Exercise3.54104,039367,812596,900Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Sale15.23154,0392,346,014442,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerJan 03Sale12.576,30979,304492,861Jan 06 08:00 PM
BENTSUR RONChief Executive OfficerJan 03Sale12.575,25766,080880,419Jan 06 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Option Exercise4.5930,000137,700506,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Sale12.6379,5001,003,890476,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 27Sale12.6830,000380,400525,929Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerOct 03Sale10.251,47515,119555,929Oct 07 07:04 PM
BENTSUR RONChief Executive OfficerOct 03Sale10.252,50525,676459,065Oct 07 07:02 PM